BRIEF published on 06/05/2024 at 18:05, 1 year 5 months ago Diversity Leader Rosario Avila is BenefitsPRO Advisor of the Year Finalist Insurance Diversity Rosario Avila BenefitsPRO Arrow Benefits Group
BRIEF published on 06/05/2024 at 18:05, 1 year 5 months ago Rosario Avila, leader en matière de diversité, est finaliste du Conseiller BenefitsPRO de l'année Assurance Diversité Rosario Avila AvantagesPRO Groupe D’avantages Arrow
PRESS RELEASE published on 06/05/2024 at 18:00, 1 year 5 months ago Diversity Leader Rosario Avila is BenefitsPRO Advisor of the Year Finalist & NABIP Equity in the Workplace Panelist Arrow Benefits Group's Rosario Avila leads in industry awards as a BenefitsPRO 2024 Advisor of the Year finalist and panelist at NABIP conference Diversity Rosario Avila Arrow Benefits Group Benefits Advisor NABIP Conference
PRESS RELEASE published on 12/12/2023 at 18:00, 1 year 11 months ago Local Benefits Advisor Honored With Prestigious Diversity in Business Award
Published on 12/05/2025 at 02:35, 4 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 26 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 56 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 1 minute ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 11 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 12 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 26 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 41 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
